BRITISH CANNABIS brings you the latest breakthrough in the medicinal cannabis sector: the intriguing possibilities of cannabis as a feasible treatment for Long Covid. UK researchers suggest that there’s promising evidence hinting at the potential of cannabis-based products in combating … Read More

In a move that has stunned Italy’s cannabidiol (CBD) industry, the government is preparing to classify CBD oil — a mainstream product widely sold as a food supplement — as a narcotic substance. Key Takeaways: On August 21, 2023, the … Read More

Top-tier MPs unite in a bipartisan call for the recalibration of the UK’s drug legislation – aiming to shift the focus from prosecution to harm reduction, with a stern recommendation to reinstate a festival-centric drug testing service by the 2024 … Read More

Introduction Introducing a seismic shift in Parkinson’s disease management with medical cannabis making waves as an innovative remedial option. Standing as the second most prevalent neurodegenerative disorder influencing the nervous system and brain, Parkinson’s is hallmarked by a plethora of … Read More

The UK’s flourishing CBD industry, represented by the Association for the Cannabinoid Industry (ACI), is urgently making an appeal. They’re entreating the Home Office to bring much-needed security and relieve the nagging uncertainty that millions of consumers currently endure by … Read More

A significant turn in US health policies has recently surfaced as top health officials encourage a descending reclassification of cannabis in a bid to align with emerging scientific insights, raising anticipations across research, industry, and consumer communities. Key Takeaways: A … Read More

In groundbreaking news shaking the cannabis arena, a recent study released in the renowned journal Psychiatry Research decimates the myth linking chronic recreational cannabis use to the onset of psychosis in adolescents considered high-risk for the disorder. This scientific investigation, … Read More

Introduction It’s a groundbreaking moment for the UK’s nascent cannabis industry as Mamedica, the country’s up-and-coming medical cannabis clinic, collaborates with Cantourage UK to present its first-ever proprietary strains of cannabis. Already the top choice for patients seeking access, both … Read More

Introduction Expect a shakeup in the medical cannabis industry in Israel as the government lays out strategies for sprawling policy alterations envisioned to streamline patient access. This monumental development that has sparked a noteworthy surge in the stock prices of … Read More

Expert psychiatrist and cannabis clinician Dr. Tahzid Ahsan unveils his insightful revelations on the potential of medical cannabis in managing symptoms of ADHD and Autism. Despite the limited formal research, the promise of cannabis as a treatment strategy is becoming … Read More